FDA Inspection 1045710 — Michal Nowicki, Prof. Uniwersytecki Szpital Kliniczny NR 1

Michal Nowicki, Prof. Uniwersytecki Szpital Kliniczny NR 1 — FEI 3005930041

The FDA completed an inspection of Michal Nowicki, Prof. Uniwersytecki Szpital Kliniczny NR 1 on Mar 23, 2018 in Lodz. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 23, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lodz (Poland)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate